Boston Scientific Corporation recalls ENDOTAK RELIANCE G/SG
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
- Products
-
- ENDOTAK RELIANCE G/SG
- Where it was sold
-
Worldwide Distribution. US nationwide. International distribution worldwide.
Nationwide
- Barcodes
00802526372766008025263772590080252637325100802526373282008025263733740080252637346600802526373558008025263736400080252637373200802526376726008025263768180080252641197700802526411984008025264220410080252642205800802526412011008025264120280080252641203500802526412042- Units affected
- 247,702 US; 344,670 OUS
- About this recall
- ENDOTAK RELIANCE G/SG, transvenous defibrillation lead, implantable cardioverter defibrillator (non-CRT); Model Nos. 0160, 0161, 0162, 0163, 0164, 0165, 0166, 0167, 0170, 0171, o182, 0173, 0174, 0175, 0176, 0177, 0180, 0182, 0183, 0184, 0185, 0186, 0187